Strategies for the treatment of intraocular inflammatory disease

Transplantation Proceedings

Volumn 30, Issue 8, 1998, Pages 4124-4125

  Nussenblatt, R B ^a   Schiffman, R ^a   Fortin, E ^a   Robinson, M ^a   Smith, J ^a   Rizzo, L ^a   Csaky, K ^a   Gery, I ^a   Waldmann, T ^a   Whitcup, S M ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTIINFECTIVE AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ANTIBODY; INTERLEUKIN 4; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RETINA S ANTIGEN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANTIGEN PURIFICATION; ANTIMICROBIAL THERAPY; CONFERENCE PAPER; CYTOMEGALOVIRUS; DRUG DELIVERY SYSTEM; DRUG TOLERABILITY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY DISEASE; INTRAOCULAR DRUG ADMINISTRATION; INTRAVITREAL DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PERIOCULAR DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN PURIFICATION; RETINITIS; TOXOPLASMOSIS; TREATMENT PLANNING; UVEITIS;

ANIMALS; ARRESTIN; CYTOKINES; DISEASE MODELS, ANIMAL; EYE PROTEINS; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY; MICE; RETINOL-BINDING PROTEINS; TH2 CELLS; UVEITIS;

EID: 0032429349     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01364-5     Document Type: Conference Paper

References (13)

1. 1. National Institutes of Health: Interim Report of the National Advisory Eye Council Support for Visual Research: Washington, DC: U.S. Department of Health, Education, and Welfare; 1976
2. 2. Nussenblatt RB: Invest Ophthalmol Vis Sci 32:3131, 1991
3. 3. Zhang JA, Davidson L, Eisenbarth G, et al: Proc Natl Acad Sci USA 88:10252, 1991
4. 4. Wang Z-Y, He B, Qiao J, et al: Neuroimmunology 63:79, 1995
5. 5. Weiner HL, Mackin GA, Matsui M, et al: Science 259:1321, 1993
6. 6. Trentham DE, Dynesius-Trentham RA, Orav EJ, et al: Science 261:1727, 1993
7. 7. Nussenblatt RB, Caspi R, Mahdi R, et al: J Immunol 144: 1689, 1990
8. 8. Gregerson DS, Obritsch WF, Donoso LA: J Immunology 151:5751, 1993
9. 9. Rizzo LV, Miller-Rivero NE, Chan CC, et al: J Clin Invest 94:1668, 1994
10. 10. Nussenblatt RB, Whitcup S, de Smet MD, et al: In Oral Tolerance: Mechanisms and Applications. Weiner HL, Mayer LF (eds): Ann NY Acad Sci, New York, 1996 Feb 13; 778:325-337.
11. 11. Nussenblatt RB, Gery I, Frederick F, et al: Am J Ophthalmol 123:583, 1997
12. 12. Martin DF, Parks DJ, Mellow SD, et al: Arch Ophthalmol 112:1531, 1994
13. 13. Chan CC, Caspi R, Mochizuki M, et al: Immunol Invest 16:39, 1987